Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) EBT (2023 - 2025)

Historic EBT for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to -$20.6 million.

  • Metagenomi's EBT rose 120.7% to -$20.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$90.0 million, marking a year-over-year decrease of 1920.35%. This contributed to the annual value of -$83.6 million for FY2024, which is 3875.77% down from last year.
  • According to the latest figures from Q3 2025, Metagenomi's EBT is -$20.6 million, which was up 120.7% from -$19.9 million recorded in Q2 2025.
  • In the past 5 years, Metagenomi's EBT registered a high of -$11.1 million during Q2 2023, and its lowest value of -$25.1 million during Q1 2024.
  • In the last 3 years, Metagenomi's EBT had a median value of -$19.9 million in 2025 and averaged -$19.0 million.
  • Its EBT has fluctuated over the past 5 years, first crashed by 8045.35% in 2024, then skyrocketed by 120.7% in 2025.
  • Metagenomi's EBT (Quarter) stood at -$16.6 million in 2023, then plummeted by 48.52% to -$24.6 million in 2024, then increased by 16.17% to -$20.6 million in 2025.
  • Its last three reported values are -$20.6 million in Q3 2025, -$19.9 million for Q2 2025, and -$24.9 million during Q1 2025.